Journal editor with ties to device maker steps down

Share this article:
The editor of the journal Neuropsychopharmacology, Charles Nemeroff, has resigned after failing to disclose financial ties to makers of a device he wrote a favorable review of. Neuropsychopharmacology has published a correction citing Nemeroff's ties to the device maker and those of the article's other eight authors. In addition to Nemeroff, seven of the authors were consultants to device maker Cyberonics. One of the article’s authors was an employee of the company. The authors’ relationships to the company were first reported in The Wall Street Journal in July. Neuropsychopharmacology published a review in July of the Cyberonics treatment, a small device implanted in the chest to deliver mild electrical pulses a nerve in the neck. The device is “a promising and well-tolerated intervention that is effective in a subset of patients with treatment-resistant depression,” the authors wrote.
Share this article:
You must be a registered member of MMM to post a comment.


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.